Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury

Ivonne Olmedo, Gonzalo Pino, Jaime A. Riquelme, Pablo Aranguiz, Magda C. Díaz, Camila López-Crisosto, Sergio Lavandero, Paulina Donoso, Zully Pedrozo, Gina Sánchez

Resultado de la investigación: Article

Resumen

Cardiomyocyte loss is the main cause of myocardial dysfunction following an ischemia-reperfusion (IR) injury. Mitochondrial dysfunction and altered mitochondrial network dynamics play central roles in cardiomyocyte death. Proteasome inhibition is cardioprotective in the setting of IR; however, the mechanisms underlying this protection are not well-understood. Several proteins that regulate mitochondrial dynamics and energy metabolism, including Mitofusin-2 (Mfn2), are degraded by the proteasome. The aim of this study was to evaluate whether proteasome inhibition can protect cardiomyocytes from IR damage by maintaining Mfn2 levels and preserving mitochondrial network integrity. Using ex vivo Langendorff-perfused rat hearts and in vitro neonatal rat ventricular myocytes, we showed that the proteasome inhibitor MG132 reduced IR-induced cardiomyocyte death. Moreover, MG132 preserved mitochondrial mass, prevented mitochondrial network fragmentation, and abolished IR-induced reductions in Mfn2 levels in heart tissue and cultured cardiomyocytes. Interestingly, Mfn2 overexpression also prevented cardiomyocyte death. This effect was apparently specific to Mfn2, as overexpression of Miro1, another protein implicated in mitochondrial dynamics, did not confer the same protection. Our results suggest that proteasome inhibition protects cardiomyocytes from IR damage. This effect could be partly mediated by preservation of Mfn2 and therefore mitochondrial integrity.

Idioma originalEnglish
Número de artículo165659
PublicaciónBiochimica et Biophysica Acta - Molecular Basis of Disease
Volumen1866
N.º5
DOI
EstadoPublished - 1 may 2020

Huella dactilar

Proteasome Endopeptidase Complex
Reperfusion Injury
Cardiac Myocytes
Mitochondrial Dynamics
Ischemia
Reperfusion
Proteasome Inhibitors
Muscle Cells
Energy Metabolism
Proteins

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Citar esto

Olmedo, Ivonne ; Pino, Gonzalo ; Riquelme, Jaime A. ; Aranguiz, Pablo ; Díaz, Magda C. ; López-Crisosto, Camila ; Lavandero, Sergio ; Donoso, Paulina ; Pedrozo, Zully ; Sánchez, Gina. / Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury. En: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2020 ; Vol. 1866, N.º 5.
@article{b6dbe8b491e74354807646511f5006ea,
title = "Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury",
abstract = "Cardiomyocyte loss is the main cause of myocardial dysfunction following an ischemia-reperfusion (IR) injury. Mitochondrial dysfunction and altered mitochondrial network dynamics play central roles in cardiomyocyte death. Proteasome inhibition is cardioprotective in the setting of IR; however, the mechanisms underlying this protection are not well-understood. Several proteins that regulate mitochondrial dynamics and energy metabolism, including Mitofusin-2 (Mfn2), are degraded by the proteasome. The aim of this study was to evaluate whether proteasome inhibition can protect cardiomyocytes from IR damage by maintaining Mfn2 levels and preserving mitochondrial network integrity. Using ex vivo Langendorff-perfused rat hearts and in vitro neonatal rat ventricular myocytes, we showed that the proteasome inhibitor MG132 reduced IR-induced cardiomyocyte death. Moreover, MG132 preserved mitochondrial mass, prevented mitochondrial network fragmentation, and abolished IR-induced reductions in Mfn2 levels in heart tissue and cultured cardiomyocytes. Interestingly, Mfn2 overexpression also prevented cardiomyocyte death. This effect was apparently specific to Mfn2, as overexpression of Miro1, another protein implicated in mitochondrial dynamics, did not confer the same protection. Our results suggest that proteasome inhibition protects cardiomyocytes from IR damage. This effect could be partly mediated by preservation of Mfn2 and therefore mitochondrial integrity.",
keywords = "Ischemia/reperfusion, Mitochondria, Mitofusin-2, Proteasome",
author = "Ivonne Olmedo and Gonzalo Pino and Riquelme, {Jaime A.} and Pablo Aranguiz and D{\'i}az, {Magda C.} and Camila L{\'o}pez-Crisosto and Sergio Lavandero and Paulina Donoso and Zully Pedrozo and Gina S{\'a}nchez",
year = "2020",
month = "5",
day = "1",
doi = "10.1016/j.bbadis.2019.165659",
language = "English",
volume = "1866",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "5",

}

Olmedo, I, Pino, G, Riquelme, JA, Aranguiz, P, Díaz, MC, López-Crisosto, C, Lavandero, S, Donoso, P, Pedrozo, Z & Sánchez, G 2020, 'Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury', Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1866, n.º 5, 165659. https://doi.org/10.1016/j.bbadis.2019.165659

Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury. / Olmedo, Ivonne; Pino, Gonzalo; Riquelme, Jaime A.; Aranguiz, Pablo; Díaz, Magda C.; López-Crisosto, Camila; Lavandero, Sergio; Donoso, Paulina; Pedrozo, Zully; Sánchez, Gina.

En: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, N.º 5, 165659, 01.05.2020.

Resultado de la investigación: Article

TY - JOUR

T1 - Inhibition of the proteasome preserves Mitofusin-2 and mitochondrial integrity, protecting cardiomyocytes during ischemia-reperfusion injury

AU - Olmedo, Ivonne

AU - Pino, Gonzalo

AU - Riquelme, Jaime A.

AU - Aranguiz, Pablo

AU - Díaz, Magda C.

AU - López-Crisosto, Camila

AU - Lavandero, Sergio

AU - Donoso, Paulina

AU - Pedrozo, Zully

AU - Sánchez, Gina

PY - 2020/5/1

Y1 - 2020/5/1

N2 - Cardiomyocyte loss is the main cause of myocardial dysfunction following an ischemia-reperfusion (IR) injury. Mitochondrial dysfunction and altered mitochondrial network dynamics play central roles in cardiomyocyte death. Proteasome inhibition is cardioprotective in the setting of IR; however, the mechanisms underlying this protection are not well-understood. Several proteins that regulate mitochondrial dynamics and energy metabolism, including Mitofusin-2 (Mfn2), are degraded by the proteasome. The aim of this study was to evaluate whether proteasome inhibition can protect cardiomyocytes from IR damage by maintaining Mfn2 levels and preserving mitochondrial network integrity. Using ex vivo Langendorff-perfused rat hearts and in vitro neonatal rat ventricular myocytes, we showed that the proteasome inhibitor MG132 reduced IR-induced cardiomyocyte death. Moreover, MG132 preserved mitochondrial mass, prevented mitochondrial network fragmentation, and abolished IR-induced reductions in Mfn2 levels in heart tissue and cultured cardiomyocytes. Interestingly, Mfn2 overexpression also prevented cardiomyocyte death. This effect was apparently specific to Mfn2, as overexpression of Miro1, another protein implicated in mitochondrial dynamics, did not confer the same protection. Our results suggest that proteasome inhibition protects cardiomyocytes from IR damage. This effect could be partly mediated by preservation of Mfn2 and therefore mitochondrial integrity.

AB - Cardiomyocyte loss is the main cause of myocardial dysfunction following an ischemia-reperfusion (IR) injury. Mitochondrial dysfunction and altered mitochondrial network dynamics play central roles in cardiomyocyte death. Proteasome inhibition is cardioprotective in the setting of IR; however, the mechanisms underlying this protection are not well-understood. Several proteins that regulate mitochondrial dynamics and energy metabolism, including Mitofusin-2 (Mfn2), are degraded by the proteasome. The aim of this study was to evaluate whether proteasome inhibition can protect cardiomyocytes from IR damage by maintaining Mfn2 levels and preserving mitochondrial network integrity. Using ex vivo Langendorff-perfused rat hearts and in vitro neonatal rat ventricular myocytes, we showed that the proteasome inhibitor MG132 reduced IR-induced cardiomyocyte death. Moreover, MG132 preserved mitochondrial mass, prevented mitochondrial network fragmentation, and abolished IR-induced reductions in Mfn2 levels in heart tissue and cultured cardiomyocytes. Interestingly, Mfn2 overexpression also prevented cardiomyocyte death. This effect was apparently specific to Mfn2, as overexpression of Miro1, another protein implicated in mitochondrial dynamics, did not confer the same protection. Our results suggest that proteasome inhibition protects cardiomyocytes from IR damage. This effect could be partly mediated by preservation of Mfn2 and therefore mitochondrial integrity.

KW - Ischemia/reperfusion

KW - Mitochondria

KW - Mitofusin-2

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=85078458322&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2019.165659

DO - 10.1016/j.bbadis.2019.165659

M3 - Article

C2 - 31891806

AN - SCOPUS:85078458322

VL - 1866

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 5

M1 - 165659

ER -